These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 30681213)

  • 1. Catalysis Concepts in Medicinal Inorganic Chemistry.
    Alonso-de Castro S; Terenzi A; Gurruchaga-Pereda J; Salassa L
    Chemistry; 2019 May; 25(27):6651-6660. PubMed ID: 30681213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intracellular Catalysis with Selected Metal Complexes and Metallic Nanoparticles: Advances toward the Development of Catalytic Metallodrugs.
    Soldevila-Barreda JJ; Metzler-Nolte N
    Chem Rev; 2019 Jan; 119(2):829-869. PubMed ID: 30618246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Editorial overview: Bioinorganic chemistry: Bio-medicinal functions of metal complexes.
    Guo Z; Zhao J
    Curr Opin Chem Biol; 2018 Apr; 43():A4-A5. PubMed ID: 29526306
    [No Abstract]   [Full Text] [Related]  

  • 4. Progress towards bioorthogonal catalysis with organometallic compounds.
    Völker T; Dempwolff F; Graumann PL; Meggers E
    Angew Chem Int Ed Engl; 2014 Sep; 53(39):10536-40. PubMed ID: 25138780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Redox activation of metal-based prodrugs as a strategy for drug delivery.
    Graf N; Lippard SJ
    Adv Drug Deliv Rev; 2012 Aug; 64(11):993-1004. PubMed ID: 22289471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioorthogonal Catalytic Activation of Platinum and Ruthenium Anticancer Complexes by FAD and Flavoproteins.
    Alonso-de Castro S; Cortajarena AL; López-Gallego F; Salassa L
    Angew Chem Int Ed Engl; 2018 Mar; 57(12):3143-3147. PubMed ID: 29359850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anticancer metallodrugs: where is the next cisplatin?
    Hanif M; Hartinger CG
    Future Med Chem; 2018 Mar; 10(6):615-617. PubMed ID: 29411994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current applications and future potential for bioinorganic chemistry in the development of anticancer drugs.
    van Rijt SH; Sadler PJ
    Drug Discov Today; 2009 Dec; 14(23-24):1089-97. PubMed ID: 19782150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Approaches to the design of catalytic metallodrugs.
    Soldevila-Barreda JJ; Sadler PJ
    Curr Opin Chem Biol; 2015 Apr; 25():172-83. PubMed ID: 25765750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Catalytic Metallodrugs: Substrate-Selective Metal Catalysts as Therapeutics.
    Yu Z; Cowan JA
    Chemistry; 2017 Oct; 23(57):14113-14127. PubMed ID: 28688119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unveiling the Potential of Transition Metal Complexes for Medicine: Translational in Situ Activation of Metal-Based Drugs from Bench to in Vivo Applications.
    Silva MJSA; Gois PMP; Gasser G
    Chembiochem; 2021 May; 22(10):1740-1742. PubMed ID: 33507625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toward Multi-Targeted Platinum and Ruthenium Drugs-A New Paradigm in Cancer Drug Treatment Regimens?
    Kenny RG; Marmion CJ
    Chem Rev; 2019 Jan; 119(2):1058-1137. PubMed ID: 30640441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stimuli-Responsive Metal Complexes for Biomedical Applications.
    Amarsy I; Papot S; Gasser G
    Angew Chem Int Ed Engl; 2022 Oct; 61(40):e202205900. PubMed ID: 35781763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stimuli-Responsive Therapeutic Metallodrugs.
    Wang X; Wang X; Jin S; Muhammad N; Guo Z
    Chem Rev; 2019 Jan; 119(2):1138-1192. PubMed ID: 30299085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Electrodrugs: an electrochemical prodrug activation strategy.
    Norman DJ; González-Fernández E; Clavadetscher J; Tucker L; Staderini M; Mount AR; Murray AF; Bradley M
    Chem Commun (Camb); 2018 Aug; 54(66):9242-9245. PubMed ID: 30066701
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metals in Cancer Research: Beyond Platinum Metallodrugs.
    Casini A; Pöthig A
    ACS Cent Sci; 2024 Feb; 10(2):242-250. PubMed ID: 38435529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metalloproteomics in conjunction with other omics for uncovering the mechanism of action of metallodrugs: Mechanism-driven new therapy development.
    Wang H; Zhou Y; Xu X; Li H; Sun H
    Curr Opin Chem Biol; 2020 Apr; 55():171-179. PubMed ID: 32200302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metallodrugs in cancer nanomedicine.
    Peña Q; Wang A; Zaremba O; Shi Y; Scheeren HW; Metselaar JM; Kiessling F; Pallares RM; Wuttke S; Lammers T
    Chem Soc Rev; 2022 Apr; 51(7):2544-2582. PubMed ID: 35262108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bioorthogonal catalytic patch.
    Chen Z; Li H; Bian Y; Wang Z; Chen G; Zhang X; Miao Y; Wen D; Wang J; Wan G; Zeng Y; Abdou P; Fang J; Li S; Sun CJ; Gu Z
    Nat Nanotechnol; 2021 Aug; 16(8):933-941. PubMed ID: 33972760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bridging informatics and medicinal inorganic chemistry: Toward a database of metallodrugs and metallodrug candidates.
    Medina-Franco JL; López-López E; Andrade E; Ruiz-Azuara L; Frei A; Guan D; Zuegg J; Blaskovich MAT
    Drug Discov Today; 2022 May; 27(5):1420-1430. PubMed ID: 35227887
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.